• Meta Health’s third-quarter 2026 loss attributable to owners narrowed 73% year over year to SGD 113,000.
• Revenue rose 7% year over year to SGD 369,000, driven by higher screening volumes at Jas Medical.
• Other income climbed to SGD 207,000, mainly due to one-off recoveries related to irregularities at Gainhealth.
• At September 30, group net liabilities totaled SGD 2.04 million, while cash and bank balances stood at SGD 162,000.
• A proposed placement announced October 26 would raise SGD 2.3 million in gross proceeds but remains subject to completion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Meta Health Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: 60NX50LOQ79AOA9M) on November 12, 2026, and is solely responsible for the information contained therein.